Of the 2,649 patients exposed to ABILIFY MAINTENA, 1,316 patients have received at least 9 ABILIFY MAINTENA 400 mg/300 mg injections, (i.e
aripiprazole. ABILIFY MAINTENA 300 mg. ABILIFY MAINTENA 400 mg. Powder and solvent for prolonged-release suspension for injection. Re-evaluation. Adopted by the
Abilify Maintena 300 mg powder and solvent for prolonged-release suspension for injection. Each vial contains 300 mg aripiprazole. Abilify Maintena 400 mg
aripiprazole. ABILIFY MAINTENA 300 mg. ABILIFY MAINTENA 400 mg. Powder and solvent for prolonged-release suspension for injection. Re-evaluation. Adopted by the
aripiprazole. ABILIFY MAINTENA 300 mg. ABILIFY MAINTENA 400 mg. Powder and solvent for prolonged-release suspension for injection. Re-evaluation. Adopted by the
Лекарства Abilify Maintena 300 mg - Powder and solvent for prolonged-release suspension for injection 300 mg.
Aripiprazole for prolonged release injectable suspension (Abilify Maintena), 300 mg or 400 mg, IM injection in the treatment of schizophrenia.
Abilify Maintena is a long-acting medicine that a healthcare professional will give to you by injection. Abilify Maintena 300 mg: AUST R
Abilify Maintena. Brand name: Abilify Maintena. Form strength aripiprazole 300 mg modified release injection [1 vial] ( ) inert substance
Comments